GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grown Rogue International Inc (XCNQ:GRIN) » Definitions » EBITDA Margin %

Grown Rogue International (XCNQ:GRIN) EBITDA Margin % : 24.61% (As of Apr. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Grown Rogue International EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Grown Rogue International's EBITDA for the three months ended in Apr. 2023 was C$1.99 Mil. Grown Rogue International's Revenue for the three months ended in Apr. 2023 was C$8.10 Mil. Therefore, Grown Rogue International's EBITDA margin for the quarter that ended in Apr. 2023 was 24.61%.


Grown Rogue International EBITDA Margin % Historical Data

The historical data trend for Grown Rogue International's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grown Rogue International EBITDA Margin % Chart

Grown Rogue International Annual Data
Trend Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Oct19 Oct20 Oct21 Oct22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -223.99 -16.54 12.82 19.22

Grown Rogue International Quarterly Data
May18 Aug18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Oct22 Jan23 Apr23 Oct23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.01 - 29.20 24.61 -

Competitive Comparison of Grown Rogue International's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Grown Rogue International's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grown Rogue International's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grown Rogue International's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Grown Rogue International's EBITDA Margin % falls into.



Grown Rogue International EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Grown Rogue International's EBITDA Margin % for the fiscal year that ended in Oct. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Oct. 2022 )/Revenue (A: Oct. 2022 )
=4.672/24.308
=19.22 %

Grown Rogue International's EBITDA Margin % for the quarter that ended in Apr. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Apr. 2023 )/Revenue (Q: Apr. 2023 )
=1.993/8.097
=24.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grown Rogue International  (XCNQ:GRIN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Grown Rogue International EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Grown Rogue International's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Grown Rogue International (XCNQ:GRIN) Business Description

Traded in Other Exchanges
Address
550 Airport Road, Medford, OR, USA, 97504
Grown Rogue International Inc is a vertically-integrated, multi-state Cannabis family of brands. The company with indoor and outdoor manufacturing facilities and consumer insight-based product categorization creates innovative products. The firm's product portfolio consists of Jack Herer, Rogue Og, Mothers Milk, White Cookies, and Critical Jack among others.
Executives
Jakob Iotte Senior Officer

Grown Rogue International (XCNQ:GRIN) Headlines

From GuruFocus